Borealis Announce EUR 370m Investment for The Wire and Cable Market

Borealis, a leading provider of innovative, value creating plastics solutions, will invest EUR 370 million in Stenungsund, Sweden, enhancing its capability to provide advanced materials for the growing wire and cable market, as well as for the Nordic packaging market.

The project, due for completion at the end of 2009, includes a new 350,000 t/y high-pressure LDPE plant, modernisation and streamlining of compounding, and related material handling facilities. 230,000 t/y of old, high-cost polyethylene capacity will be shutdown.

This significant investment builds upon the cross-linkable polyethylene (XLPE) capacity coming on stream during the second half of this year. It also reinforces Borealis’ commitment to the wire and cable industry and the development of infrastructure systems that ensure safe and reliable electricity supplies to consumers and industries.

“With well-known brands such as Supercure® and Visico®, Borealis is already an established provider of high value added materials for wire and cable infrastructure applications,” says Borealis Polyolefins Executive Vice President David Rolph. “Investment is essential for value creation in this business. We are building on our leadership and experience in the wire and cable, and advanced packaging markets, to provide advantages for the entire value chain.”

“This investment will also enable us to maximise the flexible feedstock-olefin-polyolefin integration at Stenungsund and, by improving our overall asset competitiveness, ensure long-term, profitable growth for the site,” adds Borealis Scandinavia General Manager Roy Vardheim. The total polyethylene capacity at Stenungsund will increase from 580,000 t/y to 700,000 t/y, making it a leading world-scale facility for advanced infrastructure applications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.